Heterogeneous immunogenicity of SARS-CoV-2 vaccines in cancer patients receiving radiotherapy.
Radiother Oncol
; 166: 88-91, 2022 01.
Article
in En
| MEDLINE
| ID: mdl-34838892
ABSTRACT
The immunogenicity of SARS-CoV-2 vaccines in cancer patients receiving radiotherapy is unknown. This prospective cohort study demonstrates that anti-SARS-CoV-2 spike antibody and neutralization titers are reduced in a subset of thoracic radiotherapy patients, possibly due to immunosuppressive conditions. Antibody testing may be useful to identify candidates for additional vaccine doses.
Key words
Full text:
1
Database:
MEDLINE
Main subject:
COVID-19
/
Neoplasms
Type of study:
Observational_studies
Limits:
Humans
Language:
En
Year:
2022
Type:
Article